Federated Hermes
IRON icon

Federated Hermes’s Disc Medicine IRON Stock Holding History

Federated Hermes’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-78
Closed -$3.46K – 2146
2023
Q2 		$3.46K Buy
+78
New +$2.77K ﹤0.01% 1944

Other funds holding IRON

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Federated Hermes's IRON Position: Q3 2023 in Review

Federated Hermes sold out of Disc Medicine (IRON) in Q3 2023, closing a stake of 78 shares — an estimated $3.46K sold.

Federated Hermes first reported a position in IRON in Q2 2023 and held it in 1 quarter. The position peaked at $3.46K in Q2 2023. 91 funds tracked by Wall St. Rank hold IRON as of Q3 2023.

  • Federated Hermes reported no remaining Disc Medicine position as of Q3 2023 after selling out during the quarter.
  • Federated Hermes sold 78 Disc Medicine shares in Q3 2023, an estimated $3.46K.
  • Federated Hermes first reported a position in Disc Medicine in Q2 2023 and held it in 1 quarter.
  • Federated Hermes's Disc Medicine position peaked at $3.46K in Q2 2023.
  • 91 funds tracked by Wall St. Rank held Disc Medicine as of Q3 2023.

Based on Federated Hermes's 13F filing for Q3 2023, filed 13 Nov 2023.